Juan is Director, Early Innovation Partnering at Johnson & Johnson Innovation, California. In this role, he focuses on pharmaceutical innovation in support of the neuroscience and discovery and product development & supply businesses. His charge is to identify licensing, collaboration, and investment opportunities highly aligned with Johnson & Johnson business strategies by building relationships with entrepreneurs, venture investors, and key opinion leaders. Previously, Juan was Investor and Board Observer at Action Potential Venture Capital where he led sourcing, research, and due diligence in bioelectronic therapeutic technologies. Juan has also held various roles in venture capital and management consulting, as well as key operational roles including Business Development Manager at Ultragenyx Pharmaceuticals. Juan is a proud mentor to underrepresented students and professionals in STEM-related fields and is a board member for the Hispanic Foundation of Silicon Valley. Juan completed his Postdoctoral Fellowship at Stanford University, where he focused on neuroscience, molecular biology, and genetics. Juan earned his B.S in Neuroscience and Ph.D. in Neurobiology from the University of California Los Angeles, and his M.B.A. from the University of California, Berkeley.
Our tagline, HR that Makes a Difference™, defines what we do. It emphasizes that human resources is a key driver of growth and contributes to a business’s bottom line. This is what sets Insperity apart.
Insperity has a long history of improving the success equation of small and midsize businesses across the country – because when businesses succeed, communities prosper.
And in today’s changing business environment, it’s our privilege to take care of an organization’s most valuable asset: its people.
Founded in 1938, Snell & Wilmer is a full-service business law firm with more than 450 lawyers practicing in 16 locations throughout the United States and in Mexico, including three offices in California. The firm represents clients ranging from large, publicly traded corporations to small businesses, individuals and entrepreneurs. Snell & Wilmer’s life science and medical technology lawyers currently represent a diverse client base from the bioscience, pharmaceutical (both prescription and OTC), medical device and healthcare industries, ranging from large publicly traded organizations to early and mid-stage start-up companies. Clients include manufacturers, distributors, inventors, researchers, venture capitalists, angel investors, engineers, product designers and vendors, in their intellectual property, transactional, litigation and various other legal matters.
For over 25 years, Biocom California has helped move the life science industry forward with transformative resources that enable companies to make meaningful connections. Biocom California harnesses the collective power and experience of the most innovative and productive life science clusters in the world, with powerful advocacy and transformative programs to help companies in their quest to improve the human condition.
HATCHspaces ®, LLC is a Los Angeles-based real estate development platform focused on simplifying the process of scientific innovation by creating purpose-built life sciences facilities for companies emerging from academic and incubator networks. With properties in various regional submarkets, HATCHspaces’® mission is to deliver the life science community state-of-the-art lab facilities at varying scales, allowing regions to retain early-stage bioscience and biotechnology start-ups emerging from research environments.
NexCore Group is a national healthcare real estate investment and development company that focuses on acquiring, developing, owning and managing healthcare facilities including medical office buildings, wellness facilities, ambulatory surgery centers, single and multi-specialty physician buildings, life sciences facilities, seniors housing communities and transitional rehabilitation centers. NexCore has completed $4.7 billion in healthcare real estate transactions throughout 29 states, developed and acquired over 14.3 million square feet of healthcare properties across the country and currently manages over $2.9 billion of healthcare facilities spanning 7.3 million square feet. The company has been recognized repeatedly as one of the Top Healthcare Real Estate Developers in the U.S. by Modern Healthcare and HREI.
Wilson Sonsini Goodrich & Rosati's legacy closely traces the birth and evolution of Silicon Valley.
For more than six decades, Wilson Sonsini has represented the technology pioneers associated with virtually every milestone innovation.
Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.
Wednesday, August 24, 2022
04:00 PM - 07:30 PM
UCI Beall Applied Innovation
5270 California Ave, Irvine, CA 92617Register Now